secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuo Therapeutics, Inc. (AURX)
CIK:        0001091596
Form:       8-K
Filed at:   2025-12-17T23:59:59+00:00
Accession:  0001437749-25-038091
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Nuo Therapeutics shareholders elect four directors and ratify auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- All four director nominees elected: David E. Jorden, Paul D. Mintz, Scott M. Pittman, C. Eric Winzer.
- Ratification of MaloneBailey LLP as auditor approved with 35,917,807 for, 12,899 against.
- Advisory vote on named executive officer compensation passed with 33,653,458 for, 40,106 against.
- Broker non-votes of 2,237,142 noted for director election and say-on-pay items.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1091596/000143774925038091/0001437749-25-038091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1091596/000143774925038091/aurx20251216c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-038091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer